Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Bear Stearns Upgrades Coventry Health to 'Attractive'


Coventry Health (CVH) shares gained ground after the company reported second-quarter EPS of $0.60, vs. $0.30 a year ago, on a 13% rise in operating revenues.

Bear Stearns upgraded the stock to attractive from neutral on the news. Analyst John Rex says the company's EPS levels appear sustainable and the stock valuation is attractive. He notes EPS was $0.13 higher than his estimate and $0.12 above the consensus forecast, driven almost entirely by a much improved medical cost ratio vs. expectations. He notes operating revenue increased 13% year-over-year on acquisition-related membership growth and strong pricing trends.

He preliminarily boosts $1.95 2002 EPS estimate to $2.31, and his $2.25 2003 forecast to $2.65, primarily on major improvement in medical cost ratio vs. his prior outlook. He set a $32 price target.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus